God has been so good to me. Several months ago I discovered I had Acute Myeloid Leukemia cancer and after a month in the hospital- I came home. I gained strength enough to walk again this week. I was not recommended for post remission or consolidation in hospital. God has blessed me- so thankful for the prayers, cards, meals, visits and just being able to spend this time at home with Jan. My neighbors have been wonderful and I have seen what the news is truly like in those around me. It has been such a wonderful time. I made this video to share some of my blessings and remind you God hears our prayers, I have not given up- God is a good God.
Here are some of the Dr. reports while I was in hospital;
Progress Notes by GENEVIEVE O'SULLIVAN, MD at 05/05/21 1034
|
IMPRESSION: 66-year-old man with:
1. AML, status post induction with idarubicin and cytarabine, initial oncologist Dr. Buckley, transitioning to Dr. Smith. His neutropenia has resolved. Platelets have normalized. Hemoglobin is stable from yesterday at 8, although down from 2 days prior 10. He has had a very rough time with this 26-day hospitalization, including extensive time in ICU on the ventilator, as outlined separately, with subsequent intermittent periods of acute hypoxic respiratory failure requiring high flow oxygen. I speak with him briefly about how all this has been for him, he is quite clear that he would not want reintubation in the event of progressive respiratory failure,, but I really have not taken the discussion any further, as there is palliative care meeting with the patient is best previously scheduled for today, see above, with patient expressing wish to transition to comfort measures only after that discussion per Dr. O'Sullivan, who has written those orders for comfort measures and DNR status. Dr. Sullivan will communicate directly Dr. Smith regarding this.
2. Acute hypoxic respiratory failure. Etiology is not entirely clear with persistent hypoxemia. I have personally reviewed his chest x-ray from yesterday, with mild pulmonary vascular congestion with stable mild basilar opacities. He did respond to a dose of furosemide at the time of his high flow requirement, now on 5 L. He had a CT angiogram which was negative for pulmonary embolism on April 10, has not had interval imaging in that regard. His renal function did worsen following that study, and currently his creatinine is 1.62. His LV systolic function was normal on echocardiogram in 4/28. In any event, he does want to focus on comfort only as of the palliative care discussion today, although if in the hospital was more comfortable on high flow he would be okay with that for a short period. He is afebrile, has resolved neutropenia, antibiotics discontinued today, as well as prophylaxis in the setting of wish for DNR only and enrolling in hospice.
3. Ogilvie syndrome. This developed in the setting of a fentanyl infusion in the ICU. He was treated with neostigmine on 4/23 and colonoscopy for decompression on 4/24. Eric continues to have bowel movements, scheduled senna is continued.
4. Cardiac tamponade with cardiogenic shock. About 6 and 50 cc of amber-colored fluid was removed by pericardiocentesis and ultimately he went for a pericardial window and drain placement, drain removed on 4/20, and repeat limited echo on 4/28 with resolution of effusion. He is tachycardic but needs of his overall goals of care have not repeated an echo.
5. Troponin bump up to 2.1 to peak in setting of his critical illness, not further assessed currently. No chest pain today. He was hospitalized in March 2021 with angina symptoms and surprisingly normal coronaries on angiographic evaluation, and was subsequent to that that his AML was diagnosed.
6. Acute kidney injury. Peak creatinine was 3.07. Nephrology followed, signed off on 4/18. Creatinine started rising again on 5/3, lisinopril was discontinued, but he is also diuresed for worsening respiratory flora at the time but creatinine is not coming down, we will not continue to monitor, continue off lisinopril.
7. Severe protein calorie malnutrition. He has been on TPN. He is increasing oral intake of milk shakes today. TPN is discontinued following completion of today's bag as noted above.
8. Subdural hematoma. The timing of onset this is unclear, it was an incidental finding on his CNS imaging, with no progression on follow-up CT on 4/29, Dr. Whitson consulted, no neurosurgical intervention recommended at that time.
9. Possible nephrogenic diabetes insipidus. Fluid management has been difficult, balancing tendency toward volume overload and respiratory failure with renal function, see off service note from Chad McBride from yesterday. In transitioning care with comfort the only goal, not desiring prolongation of life, not following further labs.
10. Melena noted earlier in his stay. Was not on PPI prior to pressure, has been on Protonix during the admission. Platelets have risen, stable H&H from yesterday to today, focusing on comfort, stop surveillance labs.
11. Delirium with critical illness. Although is quite fatigued, appears resolved, able to coherently tell me details about his life, children, etc.
Progress Notes by GENEVIEVE O'SULLIVAN, MD at 04/28/21 0958
|
Consults by GENEVIEVE O'SULLIVAN, MD at 04/26/21 1012
Consult Orders | |||||||||||
1. Inpatient consult to Palliative Care [65148291] ordered by Simita Singh, MD at 04/25/21 0917 |
4-18-21- Dr. Buckley;
Assessment/Recommendations: 66 y.o. male with AML Monoblastic subtype, with critically illness at presentation and initiation of induction chemotherapy. He will complete his civi ARA-C in approximately 24 hours. This will complete his induction chemotherapy, and treatment recommendations are to continue aggressive care, treat and prevent infections, transfuse prn. He will remain pancytopenic for 2-3 additional weeks, and is at risk of bleeding, and infection during that time.
Tumor lysis labs are stable to improved.
Transfusion guidelines hgb 7.5 or less, platelets 10 or less. Irradiated, leukoreduced, pathogen free products. Today he will receive platelets in addition to 2 units red blood cells.
I would continue aggressive transfusion support, IV antibiotics, avoid suppositories if possible, try to get bowel moving from above.
4-15-21- Dr. Buckley;
Assessment/Recommendations: 66 y.o. male with a recent history of a type II NSTEMI who had what appeared to be a transient bicytopenia with self resolving neutropenia and very mild thrombocytopenia that was followed by 2 to 3 weeks of progressive constitutional symptoms and an elevated white count above 30,000 blasts on the peripheral smear review concerning for AML. Bone marrow biopsy and flow cytometric analysis of peripheral blood returned positive for AML with
monotypic differentiation. FISH for PML/RARA was negative.
Cytogenetics normal. FLT3-. Genomics pending currently appears to be standard risk.
#AML
-Today is day 6 of 7+3, day 3 of idarubicin held due to hemodynamic instability, cytarabine held for 2 days during severe hemodynamic instability and need for pericardiocentesis now restarted and on fourth day of administration.
-He is still on 2 pressors he was able to come off of Levophed at some point today but after diuresis for volume management which he responded well to in regards to urine output he had worsening hypotension and is now back on both pressors with Levophed and vasopressin.
-Access is by PICC line
-TTE showed a normal EF
-His LDH is downtrending, his phosphorus is up trending secondary to lysis and acute renal failure
-His renal failure secondary to leukemia and ATN, responded well to a diuretic challenge today. Currently not needing dialysis.
-Plan to continue broad-spectrum antimicrobial coverage until he is no longer neutropenic. Currently on acyclovir, meropenem, and posaconazole
-His lack of improvement in mental status during sedation vacation today is somewhat concerning, does withdraw to noxious stimuli
-Continue standard transfusion threshold with hemoglobin of 7.5 or less, platelets 10 or less spontaneously, 20 unless febrile, as needed if bleeding.
-He will need irradiated packed red blood cells due to his neutropenia
Prognosis continues to be guarded but his intent of treatment is definitive in nature with a prognosis measured in years if he is able to recover from acute events.
4-13-21- Dr. Buckley;
Assessment/Recommendations: 66 y.o. male with a recent history of a type II NSTEMI who had what appeared to be a transient bicytopenia with self resolving neutropenia and very mild thrombocytopenia that was followed by 2 to 3 weeks of progressive constitutional symptoms and an elevated white count above 30,000 blasts on the peripheral smear review concerning for AML. Bone marrow biopsy and flow cytometric analysis of peripheral blood returned positive for AML with monotypic differentiation. FISH for PML/RARA was negative.
#AML
-Today is day 4 of 7+3, day 3 of idarubicin held due to hemodynamic instability cytarabine also held initially. His hemodynamics have improved with the interventions today including pressor support, intubation, pericardiocentesis. We will plan to continue continuous infusion cytarabine. If he is able to improve and come off of pressors we can consider adding in his last day of idarubicin.
-White blood cell count 4.5 he is now neutropenic with an ANC of 0.9 hemoglobin stable at 8.6 platelets low at 20
-Access is by PICC line
-TTE showed a normal EF
-His LDH is downtrending, his phosphorus is up trending secondary to lysis and acute renal failure
-Urine output continues to worsen. Think there are certainly some contribution from infiltration from AML potentially also some ATN from his hemodynamic instability.
-Plan to continue broad-spectrum antimicrobial coverage until he is no longer neutropenic. Currently on acyclovir, meropenem, and planning to add posaconazole for prophylaxis due to his anticipated long-term neutropenia.
Prognosis continues to be guarded. His hemodynamics have improved throughout the day after his pericardiocentesis. His LDH continues to downtrend his overall burden of AML should be improving. Hopefully he is passed the initial severe inflammatory response from the degranulation process secondary to his aggressive leukemia and also the cytotoxic effects from his chemotherapy on his leukemia. Updated his wife today regarding the details and an additional 30-minute advanced care planning conversation.